Edina, B.C. and Rinaldi, I. 2022. Effectiveness of Bendamustine-Rituximab Compared to R-CHOP/R-CVP as a First-Line Treatment of Indolent Non-Hodgkin’s Lymphoma or Mantle-Cell Lymphoma. Acta Medica Indonesiana. 54, 2 (Jul. 2022), 316.